Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19

NCT05386446 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Respiratory Infection

Interventions

DRUG: Interferon gamma human recombinant (IFN-G)

Sponsor

SPP Pharmaclon Ltd.